论文部分内容阅读
目的:研究子宫肉瘤中bcl-2、p53和nm23的表达及其与预后的关系。方法:对15例子宫肉瘤患者的临床资料进行回顾性分析,并应用免疫组织化学技术检测bcl-2、p53和nm23的表达。结果:bcl-2、p53及nm23的阳性率表达分别为40%(6/15)、73.3%(11/15)、26.7%(4/15)。结论:bcl-2、p53及nm23在子宫肉瘤中有表达,且联合表达与临床预后有联系。
Objective: To study the expression of bcl-2, p53 and nm23 in uterine sarcoma and its relationship with prognosis. Methods: The clinical data of 15 patients with uterine sarcoma were retrospectively analyzed. The expressions of bcl-2, p53 and nm23 were detected by immunohistochemistry. Results: The positive rates of bcl-2, p53 and nm23 were 40% (6/15), 73.3% (11/15) and 26.7% (4/15), respectively. Conclusion: The expressions of bcl-2, p53 and nm23 in uterine sarcoma are correlated with clinical prognosis.